Narayanan Surenderan
Director
Pharmacokinetics
VClinBio
India
Biography
Dr. Narayanan Surendran (Suri) has extensive drug discovery and development experience with specialization in ADME cross all therapeutic areas, including hit to lead characterization for several projects. Suri is President of RythRx Therapeutics andConsultant at TSRL Inc. Previously, Suri was Director of Pharmacokinetics at Pfizer Global Research and Development (USA), and Vice President of Drug Metabolism and Pharmacokinetics (DMPK) for Orchid Research Laboratories Limited (India). He also was at Parke Davis and DuPont Merck, executing DMPK projects for NCEs. He led projects involving prodrug development and NAFLDresearch. He obtained his PhD at University of Arizona and has several patents and peer-reviewed research publications.
Research Interest
Pharmacokinetics
